X0508 4 2025-01-30 false 0001831363 Terns Pharmaceuticals, Inc. TERN 0001872564 Burroughs Amy L. C/O TERNS PHARMACEUTICALS, INC. 1065 EAST HILLSDALE BLVD., SUITE 100 FOSTER CITY CA 94404 true true false false Chief Executive Officer false Common Stock 2024-11-30 4 P false 510.00 5.11 A 19609.00 D Stock Option (Right to Buy) 4.64 2025-01-30 4 A false 1075000.00 0.00 A 2035-01-29 Common Stock 1075000.00 1075000.00 D Includes an additional 510 shares acquired by the reporting person under the Issuer's 2021 Employee Stock Purchase Plan on November 30, 2024 that was not previously reported on the reporting person's Form 4 filed on December 9, 2024 due to an administrative error. 25% of the shares subject to the option vest on the first anniversary measured from January 1, 2025 (the "Vesting Commencement Date"), and 1/48th of the total number of shares vest monthly thereafter, such that 100% of the shares subject to the option will be fully vested on the fourth anniversary of the Vesting Commencement Date. /s/ David Strauss, as Attorney-in-Fact for Amy L. Burroughs 2025-02-03